Biesold C, Köhler U, Horn L C, Bilek K, Kade R, Emmert C
Department of Gynecology and Obstetrics, University of Leipzig, Germany.
Arch Gynecol Obstet. 1995;256(3):147-53. doi: 10.1007/BF01314643.
The relation between expression of several splicing variants of the CD 44 glycoprotein by tumor cells and the increased risk of metastases was discussed recently. By means of an immunocytochemical study (imprint cytology specimens from 94 invasive cervical carcinomas) we have shown a significant correlation between expression of CD 44 v6 and invasion of lymphatic vessels, lymphangiosis carcinomatosa in the primary tumor and the total number of positive pelvic lymph nodes. Expression of CD 44 v6 was not correlated with staging, grading and histological type. CD 44 v6 could therefore be considered as a predictor of lymphatic metastases in cervical carcinoma.
肿瘤细胞中CD44糖蛋白几种剪接变体的表达与转移风险增加之间的关系最近得到了讨论。通过一项免疫细胞化学研究(对94例浸润性宫颈癌的印片细胞学标本),我们发现CD44 v6的表达与淋巴管浸润、原发性肿瘤中的癌性淋巴管炎以及盆腔阳性淋巴结总数之间存在显著相关性。CD44 v6的表达与分期、分级和组织学类型无关。因此,CD44 v6可被视为宫颈癌淋巴转移的一个预测指标。